Charlotta Wallinder

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT₂ Receptor Agonist

Yiqian Wan, Charlotta Wallinder, Bianca Plouffe et al. · Journal of Medicinal Chemistry · 2004 · 330 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats

Michaël Shum, Sandra Pinard, Marie‐Odile Guimond et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012 · 58 citations

Life Sciences, Endocrinology, Pharmacology +17

First Reported Nonpeptide AT₁Receptor Agonist (L-162,313) Acts as an AT₂Receptor Agonist in Vivo

Yiqian Wan, Charlotta Wallinder, Berndt Johansson et al. · Journal of Medicinal Chemistry · 2004 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

One-Pot, Two-Step, Microwave-Assisted Palladium-Catalyzed Conversion of Aryl Alcohols to Aryl Fluorides via Aryl Nonaflates

Johan Wannberg, Charlotta Wallinder, Meltem Ceylan‐Ünlüsoy et al. · The Journal of Organic Chemistry · 2013 · 42 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

From the First Selective Non-Peptide AT₂Receptor Agonist to Structurally Related Antagonists

A. M. S. Murugaiah, Xiongyu Wu, Charlotta Wallinder et al. · Journal of Medicinal Chemistry · 2012 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +13